Repurposing of Verapamil as a Beta Cell Survival Therapy in T1D

Grant

Date/time Interval

  • October 1, 2014 - September 30, 2019
  • Total Award Amount

  • 2098675.00
  • Direct Costs

  • 1907888.00
  • Sponsor Award Id

  • 3-SRA-2014-302-M-R
  • Contributor

  • Anath Shalev   Principal Investigator  
  • Fernando Ovalle   Investigator  
  • Guanlan Xu   Investigator